Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.09.24 | CSE Bulletin: Delist - Bhang Inc. (BHNG) | 82 | Newsfile | le 3 septembre/September 2024
The subordinate voting shares of Bhang Inc. will be delisted from the CSE at market close today, September 3, 2024.
Bhang Inc. is currently suspended. See Bulletin... ► Artikel lesen | |
03.09.24 | First National Corporation and Touchstone Bankshares, Inc. Announce Receipt of Shareholders Approvals for Merger | 109 | GlobeNewswire (Europe) | STRASBURG, Va. and PRINCE GEORGE, Va., Sept. 03, 2024 (GLOBE NEWSWIRE) -- At separate shareholder meetings held on August 29, 2024, First National Corporation (NASDAQ: FXNC) (the "Company" or "First... ► Artikel lesen | |
03.09.24 | Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value | 141 | GlobeNewswire (Europe) | Semnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, "Scilex"), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the "SPAC") announce the... ► Artikel lesen | |
03.09.24 | Guardian Capital Group Limited completes its acquisition of Galibier Capital Management Ltd. | 122 | GlobeNewswire (Europe) | TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Guardian Capital Group Limited (Guardian) (TSX: GCG; GCG.A) announced today that it has completed its acquisition of Galibier Capital Management Ltd. (Galibier)... ► Artikel lesen | |
03.09.24 | Ascendis Pharma Reports Second Quarter 2024 Financial Results | 172 | GlobeNewswire (Europe) | YORVIPATH approved by U.S. Food & Drug Administration (FDA) as the first and only treatment of hypoparathyroidism in adultsTransCon CNP (navepegritide) pivotal ApproaCH Trial topline results expected... ► Artikel lesen | |
03.09.24 | Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed | 77 | GlobeNewswire (Europe) | ANKARA, Turkey, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ("Company") and Atlantic Logistics announce there will be no merger with KARINCA Logistics. The previous... ► Artikel lesen | |
03.09.24 | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 90 | GlobeNewswire (Europe) | SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small... ► Artikel lesen | |
03.09.24 | Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024 | 130 | GlobeNewswire (Europe) | NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the "Company"), a special purpose acquisition company, announced today that on August 2... ► Artikel lesen | |
03.09.24 | Zymeworks Inc.: Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c) | 111 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics... ► Artikel lesen | |
03.09.24 | Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety | 229 | GlobeNewswire (Europe) | NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to... ► Artikel lesen | |
03.09.24 | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida | 299 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for... ► Artikel lesen | |
03.09.24 | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 251 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based... ► Artikel lesen | |
03.09.24 | Osisko Mining Inc.: Osisko Mining Obtains Interim Order for Plan of Arrangement; Update on Special Meeting for Gold Fields Transaction | 350 | GlobeNewswire (Europe) | TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Osisko Mining Inc. ("Osisko") (TSX:OSK) is pleased to announce that it has obtained an interim order ("Interim Order") from the Ontario Superior Court of... ► Artikel lesen | |
03.09.24 | Advanced Micro Devices, Inc.: AMD Appoints AI Industry Veteran Keith Strier to Expand Global AI Capabilities and Engagements | 140 | GlobeNewswire (Europe) | SANTA CLARA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced that Keith Strier has joined the company as senior vice president of global AI markets. Strier has more than... ► Artikel lesen | |
03.09.24 | INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement | 147 | GlobeNewswire (Europe) | NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) ("INNOVATE" or the "Company") announced today that it has received a letter from the New York Stock Exchange ("NYSE") dated... ► Artikel lesen | |
03.09.24 | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 91 | GlobeNewswire (Europe) | BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
03.09.24 | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 263 | GlobeNewswire (Europe) | BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on August 30, 2024... ► Artikel lesen | |
03.09.24 | ParaZero Technologies Ltd.: ParaZero Announces First Half of 2024 Financial Results | 219 | GlobeNewswire (Europe) | TEL AVIV, Israel, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company" or "ParaZero"), an aerospace company focused on drone safety systems for defense and commercial... ► Artikel lesen | |
03.09.24 | Sportsman's Warehouse Holdings, Inc. Announces Second Quarter 2024 Financial Results | 153 | GlobeNewswire (Europe) | WEST JORDAN, Utah, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the "Company") (Nasdaq: SPWH) today announced financial results for the thirteen... ► Artikel lesen | |
03.09.24 | Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter | 140 | GlobeNewswire (Europe) | Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
STEYR MOTORS | 8.406 |
RENK GROUP | 6.580 |
RHEINMETALL | 5.897 |
NEL | 4.958 |
NVIDIA | 4.270 |
TESLA | 3.854 |
THYSSENKRUPP | 3.443 |
MUTARES | 3.066 |
HENSOLDT | 2.800 |
BYD | 2.674 |
DEUTZ | 2.657 |
PUMA | 2.385 |
D-WAVE QUANTUM | 1.956 |
TUI | 1.893 |
SFC ENERGY | 1.801 |
BAYER | 1.748 |
XIAOMI | 1.677 |
EVOTEC | 1.547 |
NORDEX | 1.482 |
COMMERZBANK | 1.346 |
DEUTSCHE BANK | 1.261 |
THYSSENKRUPP NUCERA | 1.212 |
NOVO NORDISK | 1.124 |
ALLIANZ | 1.111 |
RWE | 1.067 |